Literature DB >> 27672208

Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.

Golam Hasnain1,2, Mohammad Sohel Shomik2, Prakash Ghosh2, Mamun Or Rashid2, Shakhawat Hossain2, Shinjiro Hamano3, Dinesh Mondal4.   

Abstract

Post-kala-azar dermal leishmaniasis (PKDL) without previous visceral leishmaniasis (VL) is a rare dermatological manifestation of Leishmania infection. To date, most of the reported cases neither showed parasitological confirmation nor explained the outcome of treatment. Herein, we report three confirmed cases that were were successfully cured after miltefosine treatment. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27672208      PMCID： PMC5154454          DOI： 10.4269/ajtmh.16-0230

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  12 in total

1.  Post-kala-azar dermal leishmaniasis in the absence of active visceral leishmaniasis.

Authors:  A M el-Hassan; H W Ghalib; E Zylstra; I A Eltoum; M S Ali; H M Ahmed
Journal:  Lancet       Date:  1990-09-22       Impact factor: 79.321

2.  Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis.

Authors:  V Ramesh; G K Katara; S Verma; P Salotra
Journal:  Br J Dermatol       Date:  2011-08       Impact factor: 9.302

3.  Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh.

Authors:  Kazi Mizanur Rahman; Shamim Islam; Muhammad Waliur Rahman; Eben Kenah; Chowdhury Mohammad Ghalib; Chowdhury Mohammad Galive; M M Zahid; James Maguire; Mahmudur Rahman; Rashidul Haque; Stephen P Luby; Caryn Bern
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

4.  Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh.

Authors:  Dinesh Mondal; Kamrul Nahar Nasrin; M Mamun Huda; Mamun Kabir; Mohammad Shakhawat Hossain; Axel Kroeger; Tania Thomas; Rashidul Haque
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

5.  Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis.

Authors:  A C Vallur; M S Duthie; C Reinhart; Y Tutterrow; S Hamano; K R H Bhaskar; R N Coler; D Mondal; S G Reed
Journal:  Clin Microbiol Infect       Date:  2013-11-18       Impact factor: 8.067

6.  Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh.

Authors:  Shamim Islam; Eben Kenah; Mohammed Ashraful Alam Bhuiyan; Kazi Mizanur Rahman; Brook Goodhew; Chowdhury Mohammad Ghalib; M M Zahid; Masayo Ozaki; M W Rahman; Rashidul Haque; Stephen P Luby; James H Maguire; Diana Martin; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2013-07-01       Impact factor: 2.345

7.  Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial.

Authors:  Shyam Sundar; Prabat Sinha; T K Jha; Jaya Chakravarty; Madhukar Rai; Nawin Kumar; Krishna Pandey; M K Narain; N Verma; V N R Das; P Das; Jonathan Berman; Byron Arana
Journal:  Trop Med Int Health       Date:  2012-11-08       Impact factor: 2.622

8.  How far are we from visceral leishmaniasis elimination in Bangladesh? An assessment of epidemiological surveillance data.

Authors:  Rajib Chowdhury; Dinesh Mondal; Vashkar Chowdhury; Shyla Faria; Jorge Alvar; Shah Golam Nabi; Marleen Boelaert; Aditya Prasad Dash
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

9.  Efficacy and safety of miltefosine in treatment of post-kala-azar dermal leishmaniasis.

Authors:  Shyam Sundar; Anup Singh; Jaya Chakravarty; Madhukar Rai
Journal:  ScientificWorldJournal       Date:  2015-01-01

10.  Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.

Authors:  V Ramesh; Himanshu Kaushal; Ashwani Kumar Mishra; Ruchi Singh; Poonam Salotra
Journal:  BMC Public Health       Date:  2015-10-26       Impact factor: 3.295
View more
  2 in total

1.  Case Report: Treatment of Widespread Nodular Post kala-Azar Dermal Leishmaniasis with Extended-Dose Liposomal Amphotericin B in Bangladesh: A Series of Four Cases.

Authors:  Ariful Basher; Shomik Maruf; Proggananda Nath; Md Golam Hasnain; Muhammod Abdul Mukit; Azim Anuwarul; Fatima Aktar; Rupen Nath; Afm Akhtar Hossain; Abul Hasnat Milton; Dinesh Mondal; Abul Khair Mohammad Sumsuzzaman; Ridwanur Rahman; M A Faiz
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

2.  Corneal complications following Post Kala-azar Dermal Leishmaniasis treatment.

Authors:  Shomik Maruf; Proggananda Nath; Muhammad Rafiqul Islam; Fatima Aktar; Azim Anuwarul; Dinesh Mondal; Ariful Basher
Journal:  PLoS Negl Trop Dis       Date:  2018-09-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.